{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:08:59Z","timestamp":1788912539290,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":97,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01 AA018873"],"award-info":[{"award-number":["R01 AA018873"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["T32 AA007463"],"award-info":[{"award-number":["T32 AA007463"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["F31 AA030214"],"award-info":[{"award-number":["F31 AA030214"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alcoholic hepatitis (AH) is an acute form of alcohol-associated liver disease with very few treatment options. Recent studies highlighted liver metabolic reprogramming in AH as an indicator of severity. We aim at identifying new intervention points to reverse liver metabolic dysregulation across varying degrees of AH. We develop 89 personalized genome-scale metabolic models by integrating a generic human cellular metabolic model with liver transcriptomics data from AH patients with varying disease severity and healthy controls. We grade the AH patients based on the model-predicted level of glycolysis reprogramming and validate the results using published metabolomics data. We test in silico gene knockdown interventions to reverse the aberrant metabolic reprogramming in AH. Knockdown of two glycolytic genes,\n                    <jats:italic>Hkdc1<\/jats:italic>\n                    and\n                    <jats:italic>Pkm<\/jats:italic>\n                    , significantly rebalance the metabolic fluxes toward a healthy liver metabolic phenotype. We use machine learning on the glycolysis fluxes to develop a quantitative glucose use reprogramming score, which correlates with AH severity and patient-specific responses to in silico gene knockdown interventions. The score was independently validated using a published AH liver transcriptomics dataset. We propose a cellular metabolism-based therapy targeting\n                    <jats:italic>Hkdc1<\/jats:italic>\n                    and\n                    <jats:italic>Pkm<\/jats:italic>\n                    in the glycolysis pathway as a potential treatment for reversing the aberrant glucose metabolism in AH.\n                  <\/jats:p>","DOI":"10.1038\/s42003-026-10407-5","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:34:14Z","timestamp":1780594454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-specific modeling identifies metabolic interventions for reversing glucose use reprogramming in alcohol-associated hepatitis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6946-3829","authenticated-orcid":false,"given":"Alexandra","family":"Manchel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-9063","authenticated-orcid":false,"given":"Radhakrishnan","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1119-7799","authenticated-orcid":false,"given":"Ramon","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8405-1037","authenticated-orcid":false,"given":"Rajanikanth","family":"Vadigepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"10407_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2011.134","volume":"8","author":"J Altamirano","year":"2011","unstructured":"Altamirano, J. & Bataller, R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat. Rev. Gastroenterol. Hepatol. 8, 491\u2013501 (2011).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10407_CR2","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMra2207599","volume":"387","author":"R Bataller","year":"2022","unstructured":"Bataller, R., Arab, J. P. & Shah, V. H. Alcohol-Associated Hepatitis. N. Engl. J. Med. 387, 2436\u20132448 (2022).","journal-title":"N. Engl. J. Med."},{"key":"10407_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cld.1092","volume":"18","author":"A Gougol","year":"2021","unstructured":"Gougol, A., Clemente-Sanchez, A., Argemi, J. & Bataller, R. Alcoholic Hepatitis. Clin Liver Dis. (Hoboken) 18, 90\u201395 (2021).","journal-title":"Clin Liver Dis. (Hoboken)"},{"key":"10407_CR4","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.3748\/wjg.v20.i20.6279","volume":"20","author":"M Chayanupatkul","year":"2014","unstructured":"Chayanupatkul, M. & Liangpunsakul, S. Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment. World J. Gastroenterol. 20, 6279\u20136286 (2014).","journal-title":"World J. Gastroenterol."},{"key":"10407_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz, H. K. et al. Alcoholic liver disease. Nat. Rev. Dis. Primers 4, 16 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10407_CR6","doi-asserted-by":"crossref","unstructured":"Hyun, J., Han, J., Lee, C., Yoon, M. & Jung, Y. Pathophysiological aspects of alcohol metabolism in the liver. Int. J. Mol. Sci. 22, (2021).","DOI":"10.3390\/ijms22115717"},{"key":"10407_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","volume":"38","author":"NA Osna","year":"2017","unstructured":"Osna, N. A., Donohue, T. M. & Kharbanda, K. K. Alcoholic liver disease: pathogenesis and current management. Alcohol Res. 38, 147\u2013161 (2017).","journal-title":"Alcohol Res"},{"key":"10407_CR8","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1053\/j.gastro.2020.12.008","volume":"160","author":"V Massey","year":"2021","unstructured":"Massey, V. et al. Integrated multiomics reveals glucose use reprogramming and identifies a novel hexokinase in alcoholic hepatitis. Gastroenterology 160, 1725\u20131740.e2 (2021).","journal-title":"Gastroenterology"},{"key":"10407_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11004-3","volume":"10","author":"J Argemi","year":"2019","unstructured":"Argemi, J. et al. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nat. Commun. 10, 3126 (2019).","journal-title":"Nat. Commun."},{"key":"10407_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/HEP.0000000000000479","volume":"81","author":"H Gilgenkrantz","year":"2025","unstructured":"Gilgenkrantz, H., Paradis, V. & Lotersztajn, S. Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma. Hepatology 81, 269\u2013287 (2025).","journal-title":"Hepatology"},{"key":"10407_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4083","volume":"5","author":"A Mardinoglu","year":"2014","unstructured":"Mardinoglu, A. et al. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun. 5, 3083 (2014).","journal-title":"Nat. Commun."},{"key":"10407_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3389\/fphys.2018.00916","volume":"9","author":"G Bidkhori","year":"2018","unstructured":"Bidkhori, G. et al. Metabolic Network-Based Identification and Prioritization of Anticancer Targets Based on Expression Data in Hepatocellular Carcinoma. Front. Physiol. 9, 916 (2018).","journal-title":"Front. Physiol."},{"key":"10407_CR13","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.celrep.2015.10.045","volume":"13","author":"E Bj\u00f6rnson","year":"2015","unstructured":"Bj\u00f6rnson, E. et al. Stratification of hepatocellular carcinoma patients based on acetate utilization. Cell Rep. 13, 2014\u20132026 (2015).","journal-title":"Cell Rep"},{"key":"10407_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005618","volume":"13","author":"H-Q Wu","year":"2017","unstructured":"Wu, H.-Q. et al. Flux balance analysis predicts Warburg-like effects of mouse hepatocyte deficient in miR-122a. PLoS Comput. Biol. 13, e1005618 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"10407_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/msb.145122","volume":"10","author":"R Agren","year":"2014","unstructured":"Agren, R. et al. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol. 10, 721 (2014).","journal-title":"Mol. Syst. Biol."},{"key":"10407_CR16","doi-asserted-by":"publisher","first-page":"e1003993","DOI":"10.1371\/journal.pcbi.1003993","volume":"10","author":"A Naik","year":"2014","unstructured":"Naik, A., Rozman, D. & Beli\u010d, A. SteatoNet: the first integrated human metabolic model with multi-layered regulation to investigate liver-associated pathologies. PLoS Comput. Biol. 10, e1003993 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"10407_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/msb.2010.62","volume":"6","author":"C Gille","year":"2010","unstructured":"Gille, C. et al. HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol. Syst. Biol. 6, 411 (2010).","journal-title":"Mol. Syst. Biol."},{"key":"10407_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9994","volume":"7","author":"T Hy\u00f6tyl\u00e4inen","year":"2016","unstructured":"Hy\u00f6tyl\u00e4inen, T. et al. Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. Nat. Commun. 7, 8994 (2016).","journal-title":"Nat. Commun."},{"key":"10407_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104949","volume":"25","author":"P Sen","year":"2022","unstructured":"Sen, P. et al. Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience 25, 104949 (2022).","journal-title":"iScience"},{"key":"10407_CR20","doi-asserted-by":"crossref","unstructured":"Manchel, A., Mahadevan, R., Bataller, R., Hoek, J. B. & Vadigepalli, R. Genome-Scale Metabolic Modeling Reveals Sequential Dysregulation of Glutathione Metabolism in Livers from Patients with Alcoholic Hepatitis. Metabolites 12, (2022).","DOI":"10.3390\/metabo12121157"},{"key":"10407_CR21","doi-asserted-by":"crossref","unstructured":"Robinson, J. L. et al. An atlas of human metabolism. Sci. Signal. 13, (2020).","DOI":"10.1126\/scisignal.aaz1482"},{"key":"10407_CR22","doi-asserted-by":"publisher","first-page":"106201","DOI":"10.1016\/j.isci.2023.106201","volume":"26","author":"N Gonz\u00e1lez-Arru\u00e9","year":"2023","unstructured":"Gonz\u00e1lez-Arru\u00e9, N., Inostroza, I., Conejeros, R. & Rivas-Astroza, M. Phenotype-specific estimation of metabolic fluxes using gene expression data. iScience 26, 106201 (2023).","journal-title":"iScience"},{"key":"10407_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ol.2012.928","volume":"4","author":"J Zheng","year":"2012","unstructured":"Zheng, J. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). Oncol. Lett. 4, 1151\u20131157 (2012).","journal-title":"Oncol. Lett."},{"key":"10407_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","volume":"34","author":"M Mueckler","year":"2013","unstructured":"Mueckler, M. & Thorens, B. The SLC2 (GLUT) family of membrane transporters. Mol. Aspects Med. 34, 121\u2013138 (2013).","journal-title":"Mol. Aspects Med."},{"key":"10407_CR25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","volume":"472","author":"A Chadt","year":"2020","unstructured":"Chadt, A. & Al-Hasani, H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflugers Arch 472, 1273\u20131298 (2020).","journal-title":"Pflugers Arch"},{"key":"10407_CR26","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.3748\/wjg.v18.i46.6771","volume":"18","author":"S Karim","year":"2012","unstructured":"Karim, S., Adams, D. H. & Lalor, P. F. Hepatic expression and cellular distribution of the glucose transporter family. World J. Gastroenterol. 18, 6771\u20136781 (2012).","journal-title":"World J. Gastroenterol."},{"key":"10407_CR27","first-page":"329","volume":"146","author":"AA Nanji","year":"1995","unstructured":"Nanji, A. A., Fogt, F. & Griniuviene, B. Alterations in glucose transporter proteins in alcoholic liver disease in the rat. Am. J. Pathol. 146, 329\u2013334 (1995).","journal-title":"Am. J. Pathol."},{"key":"10407_CR28","doi-asserted-by":"publisher","first-page":"G1180","DOI":"10.1152\/ajpgi.00377.2013","volume":"307","author":"S Karim","year":"2014","unstructured":"Karim, S. et al. Dysregulated hepatic expression of glucose transporters in chronic disease: contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptake. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G1180\u2013G1190 (2014).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10407_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01539-7","volume":"20","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK\/mTOR signaling pathway. Cancer Cell Int. 20, 450 (2020).","journal-title":"Cancer Cell Int"},{"key":"10407_CR30","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/cas.15692","volume":"114","author":"M-Q Wang","year":"2023","unstructured":"Wang, M.-Q. et al. HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer. Cancer Sci. 114, 1365\u20131377 (2023).","journal-title":"Cancer Sci"},{"key":"10407_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04999-z","volume":"13","author":"MW Khan","year":"2022","unstructured":"Khan, M. W. et al. The hexokinase \u201cHKDC1\u201d interaction with the mitochondria is essential for liver cancer progression. Cell Death Dis. 13, 660 (2022).","journal-title":"Cell Death Dis"},{"key":"10407_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/bj0940353","volume":"94","author":"PD Dawkins","year":"1965","unstructured":"Dawkins, P. D. & Dickens, F. The oxidation of d- and l-glycerate by rat liver. Biochem. J. 94, 353\u2013367 (1965).","journal-title":"Biochem. J."},{"key":"10407_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1042\/bj1460277","volume":"146","author":"DH Williamson","year":"1975","unstructured":"Williamson, D. H. & Ellington, E. V. Hydroxypyruvate as a gluconeogenic substrate in rat hepatocytes. Biochem. J. 146, 277\u2013279 (1975).","journal-title":"Biochem. J."},{"key":"10407_CR34","doi-asserted-by":"crossref","unstructured":"Ma, J. et al. Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure. The Journal of Clinical Investigation (2022).","DOI":"10.1172\/JCI157780"},{"key":"10407_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4103\/0253-7613.96297","volume":"44","author":"K Rasineni","year":"2012","unstructured":"Rasineni, K. & Casey, C. A. Molecular mechanism of alcoholic fatty liver. Indian J. Pharmacol. 44, 299\u2013303 (2012).","journal-title":"Indian J. Pharmacol."},{"key":"10407_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3727\/105221618X15361728786767","volume":"19","author":"S Achanta","year":"2019","unstructured":"Achanta, S. et al. Single-Cell Gene Expression Analysis Identifies Chronic Alcohol-Mediated Shift in Hepatocyte Molecular States After Partial Hepatectomy. Gene. Expr. 19, 97\u2013119 (2019).","journal-title":"Gene. Expr"},{"key":"10407_CR37","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1194\/jlr.M017368","volume":"52","author":"RD Clugston","year":"2011","unstructured":"Clugston, R. D. et al. Altered hepatic lipid metabolism in C57BL\/6 mice fed alcohol: a targeted lipidomic and gene expression study. J. Lipid Res. 52, 2021\u20132031 (2011).","journal-title":"J. Lipid Res."},{"key":"10407_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1194\/jlr.R119000547","volume":"61","author":"S Jeon","year":"2020","unstructured":"Jeon, S. & Carr, R. Alcohol effects on hepatic lipid metabolism. J. Lipid Res. 61, 470\u2013479 (2020).","journal-title":"J. Lipid Res."},{"key":"10407_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/0300-1652.108886","volume":"54","author":"JP Phukan","year":"2013","unstructured":"Phukan, J. P., Sinha, A. & Deka, J. P. Serum lipid profile in alcoholic cirrhosis: A study in a teaching hospital of north-eastern India. Niger. Med. J. 54, 5\u20139 (2013).","journal-title":"Niger. Med. J."},{"key":"10407_CR40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1530-0277.2009.01111.x","volume":"34","author":"Z Wang","year":"2010","unstructured":"Wang, Z., Yao, T. & Song, Z. Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver. Alcohol. Clin. Exp. Res. 34, 471\u2013478 (2010).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10407_CR41","first-page":"7095684","volume":"2019","author":"B Li","year":"2019","unstructured":"Li, B. et al. Alcohol induces more severe fatty liver disease by influencing cholesterol metabolism. Evid. Based Complement. Alternat. Med. 2019, 7095684 (2019).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10407_CR42","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/hep4.1699","volume":"5","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Metabolomic Analysis Uncovers Energy Supply Disturbance as an Underlying Mechanism of the Development of Alcohol-Associated Liver Cirrhosis. Hepatol. Commun. 5, 961\u2013975 (2021).","journal-title":"Hepatol. Commun."},{"key":"10407_CR43","doi-asserted-by":"publisher","unstructured":"Lu, S. C. Dysregulation of glutathione synthesis in liver disease. Liver Research https:\/\/doi.org\/10.1016\/j.livres.2020.05.003 (2020).","DOI":"10.1016\/j.livres.2020.05.003"},{"key":"10407_CR44","doi-asserted-by":"publisher","first-page":"14652","DOI":"10.3748\/wjg.v20.i40.14652","volume":"20","author":"A Rocco","year":"2014","unstructured":"Rocco, A., Compare, D., Angrisani, D., Sanduzzi Zamparelli, M. & Nardone, G. Alcoholic disease: liver and beyond. World J. Gastroenterol. 20, 14652\u201314659 (2014).","journal-title":"World J. Gastroenterol."},{"key":"10407_CR45","doi-asserted-by":"publisher","first-page":"1242955","DOI":"10.3389\/fphar.2023.1242955","volume":"14","author":"S Li","year":"2023","unstructured":"Li, S., Hao, L. & Hu, X. Natural products target glycolysis in liver disease. Front. Pharmacol. 14, 1242955 (2023).","journal-title":"Front. Pharmacol."},{"key":"10407_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui, L. Energy metabolism in the liver. Compr. Physiol. 4, 177\u2013197 (2014).","journal-title":"Compr. Physiol."},{"key":"10407_CR47","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1053\/gast.2002.33613","volume":"122","author":"JB Hoek","year":"2002","unstructured":"Hoek, J. B., Cahill, A. & Pastorino, J. G. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology 122, 2049\u20132063 (2002).","journal-title":"Gastroenterology"},{"key":"10407_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1042\/bj3490519","volume":"349","author":"A Marcinkeviciute","year":"2000","unstructured":"Marcinkeviciute, A. et al. Kinetics and control of oxidative phosphorylation in rat liver mitochondria after chronic ethanol feeding. Biochem. J. 349, 519\u2013526 (2000).","journal-title":"Biochem. J."},{"key":"10407_CR49","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jhep.2014.02.014","volume":"60","author":"T Nishikawa","year":"2014","unstructured":"Nishikawa, T. et al. A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J. Hepatol. 60, 1203\u20131211 (2014).","journal-title":"J. Hepatol."},{"key":"10407_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5023-0","volume":"18","author":"W-W Lv","year":"2018","unstructured":"Lv, W.-W. et al. Effects of PKM2 on global metabolic changes and prognosis in hepatocellular carcinoma: from gene expression to drug discovery. BMC Cancer 18, 1150 (2018).","journal-title":"BMC Cancer"},{"key":"10407_CR51","doi-asserted-by":"publisher","first-page":"250","DOI":"10.14218\/GE.2023.00038","volume":"22","author":"M Jadhav","year":"2023","unstructured":"Jadhav, M., Sharma, S., Kalmegh, V., Kapoor, S. & Shard, A. Moonlighting effects of pyruvate kinase M2 in chronic liver diseases. Gene Expr. 22, 250\u2013257 (2023).","journal-title":"Gene Expr"},{"key":"10407_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1667","volume":"3","author":"G Panasyuk","year":"2012","unstructured":"Panasyuk, G. et al. PPAR\u03b3 contributes to PKM2 and HK2 expression in fatty liver. Nat. Commun. 3, 672 (2012).","journal-title":"Nat. Commun."},{"key":"10407_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14813-y","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma. Sci. Rep. 7, 15294 (2017).","journal-title":"Sci. Rep."},{"key":"10407_CR54","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fcell.2018.00138","volume":"6","author":"NCW Lee","year":"2018","unstructured":"Lee, N. C. W., Carella, M. A., Papa, S. & Bubici, C. High expression of glycolytic genes in cirrhosis correlates with the risk of developing liver cancer. Front. Cell Dev. Biol. 6, 138 (2018).","journal-title":"Front. Cell Dev. Biol."},{"key":"10407_CR55","doi-asserted-by":"crossref","unstructured":"Inomata, Y. et al. Downregulation of miR-122-5p Activates Glycolysis via PKM2 in Kupffer Cells of Rat and Mouse Models of Non-Alcoholic Steatohepatitis. Int. J. Mol. Sci. 23, (2022).","DOI":"10.3390\/ijms23095230"},{"key":"10407_CR56","doi-asserted-by":"publisher","first-page":"G387","DOI":"10.1152\/ajpgi.00054.2019","volume":"317","author":"P Zhao","year":"2019","unstructured":"Zhao, P. et al. Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation. Am. J. Physiol. Gastrointest. Liver Physiol. 317, G387\u2013G397 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10407_CR57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.omtn.2021.12.017","volume":"27","author":"J Tan","year":"2022","unstructured":"Tan, J. et al. DRAM1 increases the secretion of PKM2-enriched EVs from hepatocytes to promote macrophage activation and disease progression in ALD. Mol. Ther. Nucleic Acids 27, 375\u2013389 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10407_CR58","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1021\/acs.jproteome.3c00009","volume":"22","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Integration of metabolomics, lipidomics, and proteomics reveals the metabolic characterization of nonalcoholic steatohepatitis. J. Proteome Res. 22, 2577\u20132592 (2023).","journal-title":"J. Proteome Res."},{"key":"10407_CR59","doi-asserted-by":"publisher","unstructured":"Liu, P. et al. HKDC1 functions as a glucose sensor and promotes metabolic adaptation and cancer growth via interaction with PHB2. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-024-01392-5 (2024).","DOI":"10.1038\/s41418-024-01392-5"},{"key":"10407_CR60","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng, J. et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 39, 126 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10407_CR61","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fphys.2019.00423","volume":"10","author":"D Shi","year":"2019","unstructured":"Shi, D. et al. Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease. Front. Physiol. 10, 423 (2019).","journal-title":"Front. Physiol."},{"key":"10407_CR62","doi-asserted-by":"publisher","first-page":"8625","DOI":"10.18632\/oncotarget.7065","volume":"7","author":"D Zhou","year":"2016","unstructured":"Zhou, D. et al. Evolving roles of circadian rhythms in liver homeostasis and pathology. Oncotarget 7, 8625\u20138639 (2016).","journal-title":"Oncotarget"},{"key":"10407_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s44324-025-00058-1","volume":"3","author":"F Gachon","year":"2025","unstructured":"Gachon, F. et al. Potential bidirectional communication between the liver and the central circadian clock in MASLD. npj Metab. Health Dis. 3, 15 (2025).","journal-title":"npj Metab. Health Dis."},{"key":"10407_CR64","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/a-1792-4240","volume":"42","author":"D Guan","year":"2022","unstructured":"Guan, D. & Lazar, M. A. Circadian regulation of gene expression and metabolism in the liver. Semin. Liver Dis. 42, 113\u2013121 (2022).","journal-title":"Semin. Liver Dis."},{"key":"10407_CR65","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ymben.2022.12.003","volume":"75","author":"S Gopalakrishnan","year":"2023","unstructured":"Gopalakrishnan, S. et al. Guidelines for extracting biologically relevant context-specific metabolic models using gene expression data. Metab. Eng. 75, 181\u2013191 (2023).","journal-title":"Metab. Eng."},{"key":"10407_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature01149","volume":"420","author":"RU Ibarra","year":"2002","unstructured":"Ibarra, R. U., Edwards, J. S. & Palsson, B. O. Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth. Nature 420, 186\u2013189 (2002).","journal-title":"Nature"},{"key":"10407_CR67","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.19472115","author":"A Manchel","year":"2026","unstructured":"Manchel, A. & Vadigepalli, R. Daniel-Baugh-Institute\/Patient-specific_AH_LiverGEMStudy: Code for the Nature Communications Biology manuscript. Zenodo https:\/\/doi.org\/10.5281\/zenodo.19472115 (2026). patient_specific_modeling.","journal-title":"Zenodo"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10407-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:02:45Z","timestamp":1788912165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10407-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10407"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10407-5","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1181"}}